Table 3.
List of publications produced 2019–2023 with bioresources obtained from the IRCCS Synlab SDN.
| Biobank sample | Title | Size | Analyte determined | Year | Journal | Ref |
|---|---|---|---|---|---|---|
| PBMCs and cell lines | Influence of breast cancer extracellular vesicles on immune cell activation: a pilot study | 5 | extracellular vesicles and immune cells | 2023 | Biology | 16 |
| BMMCs | A comprehensive analysis of the expression profiles of KCTD proteins in acute lymphoblastic leukemia: evidence of selective expression of KCTD1 in T-ALL | 34 | lncRNA | 2023 | Journal of clinical medicine | 17 |
| Cell lines | The oncosuppressive properties of KCTD1: its role in cell growth and mobility | 2 | Proteins and genes expression | 2023 | Biology | 18 |
| Plasma | A peripheral signature of Alzheimer’s disease featuring microbiota-gut-brain axis markers | 84 | Cytokines and ultrasensitive neuroproteins detection | 2023 | Alzheimer’s research and therapy | 19 |
| Cell lines | Caveolin-mediated internalization of Fmoc-FF nanogels in breast cancer cell lines | 6 | Protein expression | 2023 | Pharmaceutics | 20 |
| Serum | Stratification of patients with coronary artery disease by circulating cytokines profile: a pilot study | 75 | Cytokines | 2023 | Journal of clinical medicine | 21 |
| BMMCs | Specific lncRNA signatures discriminate childhood acute leukaemias: a pilot study | 34 | lncRNA | 2022 | Cancer cell international | 22 |
| Plasma | An innovative approach for the evaluation of prolonged disorders of consciousness using NF-L and GFAP biomarkers: a pivotal study | 16 | Proteins | 2022 | Scientific reports | 23 |
| Serum | SARS-CoV-2 antibody responses before and after a third dose of the BNT162b2 vaccine in Italian healthcare workers aged ≤ 60 years: one year of surveillance | 186 | Proteins | 2022 | Frontiers in immunology | 24 |
| Breast tissues | Identification of immune cell components in breast tissues by a multiparametric flow cytometry approach | 29 | Proteins | 2022 | Cancers | 25 |
| Breast tissues and cell lines | KCTD15 Is Overexpressed in her2 + Positive Breast Cancer Patients and Its Silencing Attenuates Proliferation in SKBR3 CELL LINE | 34 | Proteins | 2022 | Diagnostics | 26 |
| BMMCs and cell lines | KCTD15 deregulation is associated with alterations of the NF-κβ signaling in both pathological and physiological model systems | 4 | Proteins | 2021 | Scientific Reports | 27 |
| BMMCs | The lncRNA TEX41 is upregulated in pediatric B-Cells Acute Lymphoblastic Leukemia and it is necessary for leukemic cell growth | 10 | lncRNA | 2021 | Biomarker Research | 28 |
| Plasma and serum | Impact of breast tumor onset on blood count, carcinoembryonic antigen, cancer antigen 15–3, and lymphoid subpopulations supported by automatic classification approach: a pilot study | 127 | Blood count, CA 15–3, and lymphocytes subsets | 2021 | Cancer Control | 29 |
| Breast cancer cells | Peptide-based hydrogels and nanogels for delivery of doxorubicin | 1 | hydrogels (HGs) and nanogels (NGs) study | 2021 | International Journal of Nanomedicine | 30 |
| Plasma, breast tissues, cell lines | miR-622 is a novel potential biomarker of breast carcinoma and impairs motility of breast cancer cells through targeting NUAK1 kinase | 98 | miR-622 | 2020 | British Journal of Cancer | 31 |
| PBMCs and cell lines | KCTD15 protein expression in peripheral blood and acute myeloid Leukemia | 17 | Proteins | 2020 | Diagnostics | 32 |
| Plasma and breast tissues | Circulating miRNAs in untreated breast cancer: an exploratory multimodality morpho-functional study | 177 | miRNA | 2019 | Cancers | 33 |
| Whole blood, PBMCs, cell lines | Purification of viable peripheral blood mononuclear cells for biobanking using a robotized liquid handling workstation | 120 | PBMCs isolations | 2019 | Journal of translational Medicine | 34 |